Pain Therapeutics Inc. (PTIE)

1.09
0.06 4.78
NASDAQ : Health Technology
Prev Close 1.15
Open 1.14
Day Low/High 1.07 / 1.16
52 Wk Low/High 0.81 / 12.80
Volume 818.14K
Avg Volume 2.80M
Exchange NASDAQ
Shares Outstanding 17.22M
Market Cap 20.49M
EPS -1.80
P/E Ratio N/A
Div & Yield N.A. (N.A)
Complete Response Letter For REMOXY®

Complete Response Letter For REMOXY®

Company Will Host Conference Call Monday, September 26th at 9:00am EDT

Pain Therapeutics Announces Advisory Committee Meeting For REMOXY® Is Not Needed

Pain Therapeutics Announces Advisory Committee Meeting For REMOXY® Is Not Needed

No Change to September 25th PDUFA Date

Pain Therapeutics Reports 2015 Financial Results And Corporate Update

Pain Therapeutics Reports 2015 Financial Results And Corporate Update

Focus in 2016 Will be on REMOXY, Fiscal Discipline and Advancing Pipeline

Pain Therapeutics Reports Q3 2015 Financial Results And Update On REMOXY

Pain Therapeutics Reports Q3 2015 Financial Results And Update On REMOXY

Focus Remains on NDA Resubmission to FDA, Targeted for Q1 2016

Short Interest In Pain Therapeutics Makes 27.2% Move

Short Interest In Pain Therapeutics Makes 27.2% Move

The most recent short interest data has been released by the NASDAQ for the 05/29/2015 settlement date, which shows a 650,044 share increase in total short interest for Pain Therapeutics Inc , to 3,037,711, an increase of 27.23% since 05/15/2015. Total short interest is just one way to look at short data; another metric that we here at Dividend Channel find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares traded.

Pain Therapeutics Announces Update On Drug Portfolio

Pain Therapeutics Announces Update On Drug Portfolio

Conference Call Tomorrow, Tuesday, at 4:30 p.m. Eastern Time

Short Interest Decreases By 20% For PTIE

Short Interest Decreases By 20% For PTIE

The most recent short interest data has been released by the NASDAQ for the 10/31/2014 settlement date, which shows a 383,304 share decrease in total short interest for Pain Therapeutics Inc , to 1,544,923, a decrease of 19.88% since 10/15/2014. Total short interest is just one way to look at short data; another metric that we here at Dividend Channel find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares traded.

Pain Therapeutics Reports Q3 2014 Financial Results

Pain Therapeutics Reports Q3 2014 Financial Results

Conference Call Today at 3:30 p.m. CT/4:30 pm ET

Pfizer (PFE) Stock Falls After Dropping Pain Drug

Pfizer (PFE) Stock Falls After Dropping Pain Drug

Shares of Pfizer (PFE) are down after the pharmaceutical company decided to discontinue its agreement to develop and commercialize the drug Remoxy, an oral formulation of oxycodone.

Pain Therapeutics To Regain Full Rights To REMOXY(R)

Pain Therapeutics To Regain Full Rights To REMOXY(R)

Conference Call Today at 8 a.m. Central Time/9:00 a.m. Eastern Time

Pain Therapeutics Expands Pipeline With FENROCK(TM), An Abuse-Deterrent Pain Patch

Pain Therapeutics Expands Pipeline With FENROCK(TM), An Abuse-Deterrent Pain Patch

Company Presenting Today at BioCentury Conference in NY

Pain Therapeutics Reports Q2 2014 Financial Results

Pain Therapeutics Reports Q2 2014 Financial Results

Conference Call Today at 4:30 p.m. Eastern Time

Relative Strength Alert For Pain Therapeutics

Relative Strength Alert For Pain Therapeutics

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

Oversold Conditions For Pain Therapeutics (PTIE)

Oversold Conditions For Pain Therapeutics (PTIE)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.